| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21fdee9b8f680c261663aa63946e1144 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2020-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2670c22d0a02ff5ce69896e12ee3c592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed27e67eacb5afce6ea32b8d79034eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43e1eae9b85bdd375f064cefce69b45c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4432a293c80bcece52c42bf91ac67c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8abfae67be79dc2bb0f1fb2a8395479e |
| publicationDate |
2022-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220027062-A |
| titleOfInvention |
DNA-dependent protein kinase inhibitors |
| abstract |
Disclosed herein are compounds of formula (I) and pharmaceutically acceptable salts thereof useful as DNA-PK inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula (I) and methods of using such compounds or compositions to treat a DNA-PK related disorder (eg, cancer). |
| priorityDate |
2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |